Mizue Hasegawa Selected Research

Mizue Hasegawa Research Topics

2	Neoplasms (Cancer) 05/2021 - 05/2018
2	Interstitial Lung Diseases (Interstitial Lung Disease) 11/2017 - 01/2017
2	Infections 01/2017 - 01/2017
2	Adenocarcinoma 01/2016 - 03/2014
1	Hypercalcemia (Milk Alkali Syndrome) 05/2018
1	Lung Neoplasms (Lung Cancer) 05/2018
1	Common Variable Immunodeficiency 11/2017
1	Diffuse panbronchiolitis 01/2017
1	Rheumatoid Arthritis 01/2017
1	Diabetes Mellitus 01/2017
1	Lung Diseases (Lung Disease) 01/2017
1	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 01/2017
1	Idiopathic Interstitial Pneumonias 01/2017
1	Carcinoma (Carcinomatosis) 01/2016
1	Congenital Cystic Adenomatoid Malformation of Lung (Cystic Adenomatoid Malformation of Lung) 03/2014
1	Cough 01/2014
1	Chronic Cough 01/2014
1	Obstructive Sleep Apnea 01/2014
1	Tobacco Use Disorder (Nicotine Dependence) 11/2010

2	ErbB Receptors (EGF Receptor)IBA 01/2016 - 03/2014
1	Claudin-4IBA 05/2021
1	Parathyroid Hormone-Related ProteinIBA 05/2018
1	Intravenous Immunoglobulins (IVIG)FDA Link 11/2017
1	HABAIBA 01/2017
1	Prednisolone (Predate)FDA LinkGeneric 01/2017
1	pirfenidoneIBA 01/2017
1	tocilizumab (atlizumab)FDA Link 01/2017
1	Etanercept (Enbrel)FDA Link 01/2017
1	Adalimumab (Humira)FDA Link 01/2017
1	Infliximab (Remicade)FDA Link 01/2017
1	Abatacept (Orencia)FDA Link 01/2017
1	Biological ProductsIBA 01/2017
1	Erythromycin (Erycette)FDA LinkGeneric 01/2017
1	Clarithromycin (Biaxin)FDA LinkGeneric 01/2017
1	Levofloxacin (Levaquin)FDA Link 01/2017
1	Tyrosine Kinase InhibitorsIBA 03/2014
1	nicotinic receptor alpha4beta2IBA 11/2010
1	Varenicline (Chantix)FDA Link 11/2010

2	Therapeutics 01/2017 - 01/2014
1	Contraindications 05/2018
1	Continuous Positive Airway Pressure 01/2014